Investment Summary |
|
|---|---|
| Date | 2019-03-10 |
| Target | Carrix |
| Sector | Transportation |
| Investor(s) | The Blackstone Group |
| Deal Type | Growth Capital |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 394.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
The Blackstone Group is a global alternative investment management firm. The Firm's investment activities span real estate, secondary investments, hedge funds, credit, infrastructure, and private equity. Blackstone's private equity group targets opportunities globally including buyout acquisitions of established companies, development projects, growth equity financings, and industry consolidations. Sectors of interest include automotive, healthcare, chemicals, industrial, commercial property, lodging, communications, media/publishing, consumer & retail, packaging, consumer products, pharmaceuticals, energy, technology, entertainment, telecommunications, financial services, theme parks, food & beverage, and transportation. Blackstone's private equity real estate group looks for opportunities across North/South America, Asia, Australia/New Zealand, and Europe. The real estate group will consider both equity and debt investments. Areas of interest include healthcare, hotel, industrial, office, residential, and retail. The Blackstone Group was formed in 1987 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 252 of 362 |
| Sector: Transportation M&A | 6 of 7 |
| Type: Growth Capital M&A Deals | 23 of 39 |
| State: Washington M&A | 1 of 3 |
| Country: United States M&A | 159 of 230 |
| Year: 2019 M&A | 5 of 16 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-02-27 |
Anthos Therapeutics
Boston, Massachusetts, United States Anthos Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of genetically and pharmacologically validated therapies for high-risk cardiovascular patient populations. Anthos Therapeutics was founded in 2019 and is based in Boston, Massachusetts. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-03-15 |
AYUMI Pharmaceutical
Tokyo, Japan AYUMI Pharmaceutical is a manufacturer and sale of medicines used in the treatment of rheumatism and other pharmaceuticals. AYUMI Pharmaceutical was founded in 2015 and is based in Tokyo, Japan. |
Buy | - |
